|
|
(Journal Article): Clinical Usefulness of the Serum Carboxypeptidase B Activation Peptide in Acute Pancreatitis
Pezzilli R, Morselli-Labate AM, Barbieri AR, Platè L (Emergency Department, Department of Internal Medicine and Gastroenterology, Central Laboratory, Sant'Orsola Hospital, University of Bologna. Bologna, Italy,
pezzilli@orsola-malpighi.med.unibo.it
)
IN:
JOP. J Pancreas (Online)
2000; 01(3):58-68
Fulltext:
HTML
PDF
ABSTRACT: OBJECTIVE: To assess the sensitivity and specificity of the serum carboxypeptidase B activation peptide in diagnosing and determining the severity of acute pancreatitis. PATIENTS: Twenty consecutive patients with acute pancreatitis were studied on admission to the Emergency Room: 11 patients had mild pancreatitis, and 9 patients, severe pancreatitis. Twenty consecutive patients with non-pancreatic acute abdomen and 20 healthy subjects were also studied. MAIN OUTCOME MEASURES: Serum carboxypeptidase B activation peptide was determined using radioimmunoassay. RESULTS: Nineteen of the 20 patients with acute pancreatitis (95.0%) had serum carboxypeptidase B activation peptide concentrations above the upper reference limit, whereas 1 of the 20 patients with non-pancreatic acute abdomen (5.0%) and none of the healthy subjects had serum levels of this protein above the upper reference limit. The serum carboxypeptidase B activation peptide concentrations of patients with severe acute pancreatitis were significantly higher than those of patients with mild acute pancreatitis on the 2(nd) (P=0.044) and 3(rd) days (P=0.028) of the study. The overall sensitivity and specificity of carboxypeptidase B activation peptide in assessing the severity of acute pancreatitis were 84.6% and 59.4%, respectively. CONCLUSIONS: Serum carboxypeptidase B activation peptide may be used simultaneously both to diagnosis and assess the severity of acute pancreatitis on admission to the Emergency Room.
TYPE OF PUBLICATION: Original Article
|
Respond
on this Journal Article!
Hint: Your Response should directly apply to Clinical Usefulness of the Serum Carboxypeptidase B Activation Peptide in Acute Pancreatitis.
Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate
subject area. The actual subject area is 2000.
|
|
|
|
|